1. Home
  2. LGND vs SOC Comparison

LGND vs SOC Comparison

Compare LGND & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • SOC
  • Stock Information
  • Founded
  • LGND 1987
  • SOC 2020
  • Country
  • LGND United States
  • SOC United States
  • Employees
  • LGND N/A
  • SOC N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • SOC
  • Sector
  • LGND Health Care
  • SOC
  • Exchange
  • LGND Nasdaq
  • SOC Nasdaq
  • Market Cap
  • LGND 2.0B
  • SOC 1.7B
  • IPO Year
  • LGND 1992
  • SOC N/A
  • Fundamental
  • Price
  • LGND $111.71
  • SOC $20.63
  • Analyst Decision
  • LGND Strong Buy
  • SOC Buy
  • Analyst Count
  • LGND 6
  • SOC 3
  • Target Price
  • LGND $144.83
  • SOC $25.00
  • AVG Volume (30 Days)
  • LGND 142.9K
  • SOC 1.1M
  • Earning Date
  • LGND 11-07-2024
  • SOC 11-25-2024
  • Dividend Yield
  • LGND N/A
  • SOC N/A
  • EPS Growth
  • LGND 160.46
  • SOC N/A
  • EPS
  • LGND 2.47
  • SOC N/A
  • Revenue
  • LGND $152,422,000.00
  • SOC N/A
  • Revenue This Year
  • LGND $23.19
  • SOC N/A
  • Revenue Next Year
  • LGND $15.08
  • SOC $606.07
  • P/E Ratio
  • LGND $45.20
  • SOC N/A
  • Revenue Growth
  • LGND N/A
  • SOC N/A
  • 52 Week Low
  • LGND $57.00
  • SOC $10.11
  • 52 Week High
  • LGND $129.90
  • SOC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • LGND 48.80
  • SOC 42.74
  • Support Level
  • LGND $119.69
  • SOC $22.42
  • Resistance Level
  • LGND $125.76
  • SOC $24.49
  • Average True Range (ATR)
  • LGND 5.73
  • SOC 1.31
  • MACD
  • LGND -0.30
  • SOC -0.08
  • Stochastic Oscillator
  • LGND 25.51
  • SOC 1.21

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About SOC Sable Offshore Corp. Common Stock

Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California.

Share on Social Networks: